Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-06-23

Clinical Trial Update: The Role of Intravenous Albumin Replacement During Abdominal Paracentesis in Patients With Malignancy Related Ascites [NA]

View source ↗

Summary

This clinical trial update examines the role of intravenous albumin replacement during abdominal paracentesis in patients with cancer-related ascites.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Intravenous human serum albumin (albumin)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Ascites, Hypotension | NA | Status: UNKNOWN